Clustering of PHENTERMINE (cas 122-09-8) HCL Drug from Online Patient Medication Reviews
-
Add time:09/10/2019 Source:sciencedirect.com
In this paper, a study to reveal hidden knowledge in the online patient medication reviews for PHENTERMINE (cas 122-09-8) HCL is presented. Phentermine HCL is used most frequently in the treatment of obesity. Obesity is a complex health disorder that affects huge amount of people. In recent years, the number of overweight people in industrialized countries has increased significantly and people who are obese are at a much higher risk for serious medical conditions such as high blood pressure, heart attack, stroke and diabetes. Considering the importance of the medication of obesity, knowledge discovery from online patient reviews is performed. Some information technologies and data mining techniques are used to discover some hidden knowledge between patient information and side effects in these reviews. Our results can give new ideas to medical researchers and pharmaceutical industry for drug safety.
We also recommend Trading Suppliers and Manufacturers of PHENTERMINE (cas 122-09-8). Pls Click Website Link as below: cas 122-09-8 suppliers
Prev:Original articleUse of PHENTERMINE (cas 122-09-8)-topiramate extended release in combination with sleeve gastrectomy in patients with BMI 50 kg/m2 or more
Next:Case ReportParadoxical topiramate-induced hyperphagia successfully treated with PHENTERMINE (cas 122-09-8) in a woman with migraine) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Study protocol and rationale for a randomized double-blinded crossover trial of PHENTERMINE (cas 122-09-8)-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa09/25/2019
- Case ReportParadoxical topiramate-induced hyperphagia successfully treated with PHENTERMINE (cas 122-09-8) in a woman with migraine09/24/2019
- Original articleUse of PHENTERMINE (cas 122-09-8)-topiramate extended release in combination with sleeve gastrectomy in patients with BMI 50 kg/m2 or more09/09/2019
- Clinical ScienceEffects of liraglutide plus PHENTERMINE (cas 122-09-8) in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial09/08/2019
- PHENTERMINE (cas 122-09-8)☆09/07/2019
- Case reportPHENTERMINE (cas 122-09-8) and Coronary Vasospasm–Induced Myocardial Infarction09/06/2019
- Lorcaserin vs. PHENTERMINE (cas 122-09-8) among non-surgical and surgical obese patients: Anthropometric, glycemic, lipid, safety and cost outcomes09/05/2019
- Letter to the EditorPHENTERMINE (cas 122-09-8) associated recurrent intracerebral hemorrhage09/04/2019